Is Adeshwar Meditex overvalued or undervalued?

As of 23 September 2025, Adeshwar Meditex's valuation grade has moved from attractive to fair, indicating a shift in market perception. The company is currently fairly valued. Key ratios include a PE ratio of 13.59, an EV to EBITDA of 8.64, and a Price to Book Value of 0.76, which suggest that the company's valuation is in line with its earnings potential and asset base.
In comparison to its peers, Adeshwar Meditex's PE ratio is significantly lower than that of Poly Medicure, which stands at 55.32, and Blue Jet Health at 32.88, both categorized as very expensive. Additionally, while Adeshwar Meditex has a PEG ratio of 4.55, Raaj Medisafe, considered very attractive, has a much lower PEG of 0.26. Recent stock performance shows Adeshwar Meditex has outperformed the Sensex over the past week and month, but it has underperformed year-to-date and over the longer term, reinforcing the notion that it is currently fairly valued amidst a fluctuating market environment.